| Closed |
SWOG-9445 |
Prognostic Factor Panel to Predict Preferred Therapy for Node Positive Postmenopausal Breast Cancer Patients (CAF vs. Tamoxifen) (a Companion Protocol to SWOG-8814 [INT-0100, CALGB-9194, EST-4188,… |
2/1/1995 |
10/1/1998 |
66% |
|
Published
|
| Closed |
SWOG-8854 |
Prognostic Value of Cytometry Measurements of Breast Cancer DNA From Postmenopausal Patients With Involved Nodes and Receptor Positive Tumors: A Companion Protocol to SWOG-8814 |
5/15/1989 |
2/15/1995 |
|
|
|
| Closed |
SWOG-8610 |
Prospective Randomized Clinical Trial of the Capillary Cloning System for Patients with Extensive Small-Cell Lung Cancer |
9/1/1988 |
11/1/1989 |
8% |
|
|
| Closed |
SWOG-8494 (INT-0036) |
Prostate - Advanced |
3/18/1985 |
7/1/1987 |
|
|
Published
|
| Closed |
SWOG-9217 |
PROSTATE CANCER PREVENTION TRIAL (PCPT) |
10/13/1993 |
12/6/1996 |
100% |
|
Published
|
| Closed |
SWOG-227 |
Protocol for Phase II Trial of Actinomycin D & Vincristine in Lung Cancer |
8/6/1968 |
8/21/1969 |
0% |
|
|
| Closed |
S0327 |
PS-341/Platinum-treated/Extensive SCLC |
9/1/2003 |
9/15/2004 |
75% |
|
Published
|
| Closed |
SWOG-9208 |
Quality of Life Companion study - Hodgkin's |
4/15/1994 |
4/24/2000 |
|
|
Published
|
| Closed |
SWOG-7983 |
Radiation Therapy in Combination with CCNU in Patients with Incompletely Resected Gliomas of the Brain, Grade I and II |
2/4/1980 |
3/22/1985 |
|
|
Published
|
| Closed |
SWOG-8890 (INT-0109) |
Radical Prostatectomy versus Radiation Therapy for Clinical Stage A2 and B Adenocarcinoma of the Prostate (N0,M0) |
4/1/1990 |
1/1/1992 |
1% |
|
|
| Closed |
SWOG-781 |
Radiotherapy - Chemotherapy (MOPP) for Stages I and II, A and B Hodgkin's |
2/14/1972 |
8/8/1978 |
|
|
Published
|
| Closed |
S1300 |
Rand Ph II of Crizotinib + Pem vs Pem in ALK+ NSCLC Pts Progressing Post Crizotinib |
8/1/2014 |
9/1/2016 |
1% |
|
|
| Closed |
S1115 |
Rando Phase II of AZD-6244 add MK-2206 vs mFOLFOX in Pts with Met Pancreatic Cancer After Chemo |
8/15/2012 |
5/15/2014 |
100% |
|
Published
|
| Closed |
S1712 |
Rando PhII Ruxolitinib + BCR-ABL TKIs in CML w/Molecular Disease |
7/20/2018 |
|
96% |
|
|
| Closed |
S1117 |
Rando PII Aza vs. Aza/Len vs. Aza/Vorin for High Risk MDS and CMML |
3/1/2012 |
11/14/2014 |
100% |
|
Published
|
| Closed |
S1310 |
Rando PII GSK1120212 vs 5-FU/Leucovorin or Capecitabine for Refractory Advanced Biliary |
2/15/2014 |
5/15/2015 |
60% |
|
|
| Closed |
S1614 |
Rando Prophylactic Antiviral HBV |
2/21/2019 |
11/15/2022 |
1% |
|
|
| Closed |
SWOG-8203/04 |
Randomized Comparison of Adriamycin, Mitoxantrone, and Bisantrene in Patients with Metastatic Breast Cancer not Previously Exposed to Intercalating Chemotherapy |
12/23/1982 |
5/1/1986 |
|
|
Published
|
| Closed |
SWOG-8514 |
Randomized Comparison of Cisplatin + 5-Fluorouracil Versus CBDCA + 5-Fluorouracil Versus Methotrexate In Advanced Squamous Cell Carcinoma of the Head and Neck, Phase III |
1/3/1985 |
3/1/1989 |
|
|
Published
|
| Closed |
SWOG-8223/24/25 |
Randomized Comparison of Drug Therapy for Squamous Cell Cancer of the Head and Neck with Early Assessment of Phase II Agents |
9/17/1982 |
1/31/1983 |
|
|
|
